Her OFC curves increased disproportionately with age. A CT-Scan performed at 6 months showed bilateral hydrocephaly (Evans' index 0.32), but no posterior fossa abnormalities. A brain MRI at 7 months showed cerebellar tonsillar herniation (CTH), hydrocephaly, and indirect signs of cerebral hypertension (hydrocephaly with enlarged subarachnoid pericerebral space). Ventricular shunting at 11 months ( Fig. 1C ) improved both the OFC, which remained at 51 cm until death, and psychomotor development.
At 19 months, she had tonic-clonic movements of right upper limb accompanied by crying and cutaneous flushing. An EEG showed slow basal rhythm and paroxysm on the left part of her brain. There was no seizure recurrence on Valproate therapy. Chest X-ray showed 11 pairs of ribs. There were no other osseous abnormalities. Thermoregulation instability appeared after the first year of life with a usual temperature between 38 and 39 C. Feeding difficulties were experienced throughout life and major milestones were delayed (unable to sit alone, no words at 17 months). She smiled easily and had good interactive contact. She died at 23 months from disseminated intravascular coagulation following a common respiratory viral infection. Autopsy was refused by the parents.
Her monozygotic twin was clinically normal, birth weight was 2,270 g (75th centile on monozygotic twin growth chart, 25th centile on singleton growth chart), length was 44 cm (10-25th centile on singleton growth chart), head circumference was 32.5 cm (50-75th centile on singleton growth chart).
Major and minor criteria have been proposed for the diagnosis of M-CM. For Franceschini et al. [2000] a M-CM diagnosis requires macrocephaly and at least two other manifestations such as overgrowth, cutis marmorata/capillary malformation, angiomata, syndactyly, or asymmetry. Whereas Robertson et al. [2000] , suggest that congenital macrocephaly and cutis marmorata/capillary malformation are obligatory plus at least 4 of the following findings: neonatal hypotonia, developmental delay, connective tissue defect, frontal bossing, midline facial nevus flammeus, cutaneous toe syndactyly, segmental overgrowth, and hydrocephalus. In a review of 75 cases of M-CM, Lapunzina et al. [2004] classified the manifestations of macrocephaly, cutis marmorata telangiectatica/ capillary malformation, and hemangioma as very frequent (>75% of cases) whilst developmental delay, hydrocephalus, frontal bossing, and thick subcutaneous tissue are frequent (25-75% of cases).
Given that this patient had macrocephaly, capillary malformation, neonatal hypotonia, developmental delay, frontal bossing, midline facial nevus flammeus, and hydrocephaly, she fulfils both proposed criteria for M-CM. She also fulfils the criteria recently suggested by Martinez-Glez et al. [2010] . She did not have body asymmetry, digital polydactyly or syndactyly, hyperelastic skin or joint hyperlaxity. Even though typical of M-CM, these features are not constant findings in M-CM [Lapunzina et al., 2004] . Moreover, the face of the proband is similar to other cases of M-CM with full lips and central facial capillary malformations. The evolution of capillary malformations, which faded with age, is also very typical. Cerebellar tonsillar herniation appears to be very common in M-CM and, as in our case, is frequently acquired with rapid progression [Conway et al., 2007; Papetti et al., 2011] . This case highlights the importance of neuroimaging follow-up of children with M-CM due to the rapid evolution of CTH. The proband also has unique features such as thermoregulation dysfunction and intracerebral calcifications, although for the latter we cannot exclude an ischemic event due to fetal distress.
To date, 132 cases of M-CM have been reported, of which the etiology remains unknown. Only three cases were associated with cytogenetic abnormalities involving skin sex chromosome mosaicism, translocation t(2;17)(p11;p13), and 16q deletion, and two individuals were born to consanguineous parents [Lapunzina et al., 2004] . The karyotype of this case, performed on two tissues (peripheral blood lymphocytes and fibroblasts) was normal (46,XX) as was array-CGH analysis on lymphocyte DNA (Agilent platform, 44k).
All reported cases were sporadic and none involved a discordant monozygotic twin (DMT). There are, however, two cases of discordant dizygotic twins with a healthy female and an affected boy [Yano and Watanabe, 2001; Conway et al., 2007] . A monozygotic twin test performed twice on two independent saliva samples confirms that the proband and her twin sister were monozygotic (short tandem repeats analyses kit PowerPlex 16 by Promega). This case is therefore the first reported monozygotic twin with M-CM.
Proteus syndrome (OMIM 176920) shares similarities with M-CM. Recently, a mosaic activating mutation was discovered in AKT1 (OMIM 164730) in individuals with Proteus syndrome [Lindhurst et al., 2011] . Using Sanger sequencing, we were unable to find this AKT1 mutation in DNA from either fibroblasts or peripheral blood lymphocytes.
The discordant phenotype of monozygotic twins is generally of nongenetic etiology. Infection screening was not performed on the proband, but the mother had positive CMV, rubella and toxoplasmosis antibody titers prior to pregnancy, and there were no serologic signs of secondary CMV infection during the pregnancy. Where DMT is of genetic origin, its variable expression can be explained by the following mechanisms. The first assumes, in the case of females, that the syndrome is X-linked and that expression, or absence, of the phenotype results from skewed X-inactivation. However, there is no evidence to suggest that M-CM is X-linked since the incidence of reported cases is equivalent in males and females (73 males (55%) vs. 59 females (45%)). Furthermore, X-inactivation profiling of the proband and her twin showed normal patterns (respectively 42/58 and 39/61). An X-inactivation pattern was determined by PCR amplification of the CAG repeat in exon 1 of the androgen receptor gene before and after DNA digestion with HpaII and CfoI. The second mechanism to consider is differential methylation patterns of imprinted genes as seen in DMT for Beckwith-Wiedemann syndrome [Tierling et al., 2011] . A third mechanism to explain DMT is a post-zygotic mutation event, leading to somatic mosaicism in the affected twin. There was no evidence of chromosome mosaicism in the affected twin, although we cannot fully exclude this possibility due to the limited number of tissue samples examined by karyotype and aCGH. Nor can we exclude the occurrence of a point mutation or methylation mosaicism in this case.
Patchy cutaneous vascular malformations [Wright et al., 2008] , body asymmetry, and general variability of clinical findings commonly seen in macrocephaly-capillary malformation are all manifestations that are consistent with a potential role for somatic mosaicism in this disorder [Clayton-Smith et al., 1997; Gripp et al., 2009] , and this case reinforces this hypothesis.
